ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published on July 18, 2008
Interactive CardioVascular and Thoracic Surgery 2008, doi:10.1510/icvts.2008.178947
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (Journal Format PDF)
Right arrow eComments: Submit
Right arrow Alert me when this article is cited
Right arrow Alert me when eComments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Chamogeorgakis, T.
Right arrow Articles by Mallios, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamogeorgakis, T.
Right arrow Articles by Mallios, D.
Related Collections
Right arrow Lung - cancer

Thoracic general

Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?

Themistokles Chamogeorgakis 1*, Costas Ieromonachos 1, Emmanouil Georgiannakis 1, Dimitrios Mallios 1

1 Attikon Hospital, Haidari, Greece

* To whom correspondence should be addressed. E-mail: thchamogeorgakis{at}yahoo.com.


   Abstract
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: 'Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?'. Altogether 225 papers were found using the reported search, of which nineteen represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. A meta-analysis published in 2005 showed a 0.7% (p=0.3659) survival difference at one year, 1.9% (p=0.5088) at 3 years and 3.6% (p=0.3603) at 5 years. The largest study prior to the meta-analysis was a randomized controlled study of 247 patients with T1N0 tumors that showed 8 locoregional recurrences in the lobectomy group compared to 21 in the sublobar group which was statistically significant. Since the meta-analysis we identified three studies, two of which showed no difference in survival and recurrence between wedge resection and lobectomy for T1N0 tumors and one that showed improved survival after lobectomy compared to wedge resection for T1N0 tumors. We conclude that wedge resection is not comparable to lobectomy for stage IA NSCLC. The increased long-term mortality associated with wedge resection is mainly due to non-cancer deaths, reflecting a higher risk patient group with many comorbid conditions. Segmental resection is comparable to lobectomy for small peripheral tumors. Sublobar resection is associated with shorter hospital stay. For bronchioalveolar carcinoma sublobar resection is recommended provided intra-operative pathologic consultation confirms pure bronchioalveolar histology without evidence of invasion, and surgical margins are free of disease. Keywords: Non-small cell lung cancer; Limited resection; Sublobar resection; Segmentectomy; Wedge resection; Lobectomy; Recurrence





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-thoracic Surgery